These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 16778113

  • 1. PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas.
    Schönleben F, Qiu W, Ciau NT, Ho DJ, Li X, Allendorf JD, Remotti HE, Su GH.
    Clin Cancer Res; 2006 Jun 15; 12(12):3851-5. PubMed ID: 16778113
    [Abstract] [Full Text] [Related]

  • 2. PIK3CA, KRAS, and BRAF mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/C) of the pancreas.
    Schönleben F, Qiu W, Remotti HE, Hohenberger W, Su GH.
    Langenbecks Arch Surg; 2008 May 15; 393(3):289-96. PubMed ID: 18343945
    [Abstract] [Full Text] [Related]

  • 3. BRAF and KRAS gene mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/IPMC) of the pancreas.
    Schönleben F, Qiu W, Bruckman KC, Ciau NT, Li X, Lauerman MH, Frucht H, Chabot JA, Allendorf JD, Remotti HE, Su GH.
    Cancer Lett; 2007 May 08; 249(2):242-8. PubMed ID: 17097223
    [Abstract] [Full Text] [Related]

  • 4. The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant.
    Yamaguchi H, Kuboki Y, Hatori T, Yamamoto M, Shimizu K, Shiratori K, Shibata N, Shimizu M, Furukawa T.
    J Pathol; 2013 Nov 08; 231(3):335-41. PubMed ID: 23893889
    [Abstract] [Full Text] [Related]

  • 5. PIK3CA mutations in head and neck squamous cell carcinoma.
    Qiu W, Schönleben F, Li X, Ho DJ, Close LG, Manolidis S, Bennett BP, Su GH.
    Clin Cancer Res; 2006 Mar 01; 12(5):1441-6. PubMed ID: 16533766
    [Abstract] [Full Text] [Related]

  • 6. Loss of PTEN expression is associated with poor prognosis in patients with intraductal papillary mucinous neoplasms of the pancreas.
    Garcia-Carracedo D, Turk AT, Fine SA, Akhavan N, Tweel BC, Parsons R, Chabot JA, Allendorf JD, Genkinger JM, Remotti HE, Su GH.
    Clin Cancer Res; 2013 Dec 15; 19(24):6830-41. PubMed ID: 24132918
    [Abstract] [Full Text] [Related]

  • 7. PIK3CA mutations in mucinous cystic neoplasms of the pancreas.
    Garcia-Carracedo D, Chen ZM, Qiu W, Huang AS, Tang SM, Hruban RH, Su GH.
    Pancreas; 2014 Mar 15; 43(2):245-9. PubMed ID: 24518503
    [Abstract] [Full Text] [Related]

  • 8. Genetic alterations in adenoma-carcinoma sequencing of intraductal papillary-mucinous neoplasm of the pancreas.
    Nakata B, Yashiro M, Nishioka N, Aya M, Yamada S, Takenaka C, Ohira M, Ishikawa T, Nishino H, Wakasa K, Hirakawa K.
    Int J Oncol; 2002 Nov 15; 21(5):1067-72. PubMed ID: 12370756
    [Abstract] [Full Text] [Related]

  • 9. Somatic mutations in PIK3CA and activation of AKT in intraductal tubulopapillary neoplasms of the pancreas.
    Yamaguchi H, Kuboki Y, Hatori T, Yamamoto M, Shiratori K, Kawamura S, Kobayashi M, Shimizu M, Ban S, Koyama I, Higashi M, Shin N, Ishida K, Morikawa T, Motoi F, Unno M, Kanno A, Satoh K, Shimosegawa T, Orikasa H, Watanabe T, Nishimura K, Harada Y, Furukawa T.
    Am J Surg Pathol; 2011 Dec 15; 35(12):1812-7. PubMed ID: 21945955
    [Abstract] [Full Text] [Related]

  • 10. Mutational analyses of multiple oncogenic pathways in intraductal papillary mucinous neoplasms of the pancreas.
    Schönleben F, Allendorf JD, Qiu W, Li X, Ho DJ, Ciau NT, Fine RL, Chabot JA, Remotti HE, Su GH.
    Pancreas; 2008 Mar 15; 36(2):168-72. PubMed ID: 18376308
    [Abstract] [Full Text] [Related]

  • 11. Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm.
    Ceppa EP, Roch AM, Cioffi JL, Sharma N, Easler JJ, DeWitt JM, House MG, Zyromski NJ, Nakeeb A, Schmidt CM.
    Surgery; 2015 Oct 15; 158(4):937-44; discussion 944-5. PubMed ID: 26173683
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA expression signatures in intraductal papillary mucinous neoplasm of the pancreas.
    Lubezky N, Loewenstein S, Ben-Haim M, Brazowski E, Marmor S, Pasmanik-Chor M, Oron-Karni V, Rechavi G, Klausner JM, Lahat G.
    Surgery; 2013 May 15; 153(5):663-72. PubMed ID: 23305591
    [Abstract] [Full Text] [Related]

  • 13. PIK3CA mutations mostly begin to develop in ductal carcinoma of the breast.
    Li H, Zhu R, Wang L, Zhu T, Li Q, Chen Q, Wang H, Zhu H.
    Exp Mol Pathol; 2010 Feb 15; 88(1):150-5. PubMed ID: 19818761
    [Abstract] [Full Text] [Related]

  • 14. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms.
    Nara S, Shimada K, Kosuge T, Kanai Y, Hiraoka N.
    Am J Surg Pathol; 2008 Feb 15; 32(2):243-55. PubMed ID: 18223327
    [Abstract] [Full Text] [Related]

  • 15. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
    Ozaki N, Ohmuraya M, Ida S, Hashimoto D, Ikuta Y, Chikamoto A, Hirota M, Baba H.
    J Hepatobiliary Pancreat Sci; 2013 Aug 15; 20(6):620-7. PubMed ID: 23475261
    [Abstract] [Full Text] [Related]

  • 16. Copy number gain of chromosome 3q is a recurrent event in patients with intraductal papillary mucinous neoplasm (IPMN) associated with disease progression.
    Durante S, Vecchiarelli S, Astolfi A, Grassi E, Casadei R, Santini D, Panzacchi R, Ricci C, Serravalle S, Tarantino G, Falconi M, Teti G, Indio V, Pession A, Minni F, Biasco G, Di Marco M.
    Oncotarget; 2016 Nov 15; 7(46):74797-74806. PubMed ID: 27566563
    [Abstract] [Full Text] [Related]

  • 17. PIK3CA gene mutations in breast carcinoma in Malaysian patients.
    Ching-Shian Leong V, Jabal MF, Leong PP, Abdullah MA, Gul YA, Seow HF.
    Cancer Genet Cytogenet; 2008 Dec 15; 187(2):74-9. PubMed ID: 19027487
    [Abstract] [Full Text] [Related]

  • 18. PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancer.
    Day FL, Jorissen RN, Lipton L, Mouradov D, Sakthianandeswaren A, Christie M, Li S, Tsui C, Tie J, Desai J, Xu ZZ, Molloy P, Whitehall V, Leggett BA, Jones IT, McLaughlin S, Ward RL, Hawkins NJ, Ruszkiewicz AR, Moore J, Busam D, Zhao Q, Strausberg RL, Gibbs P, Sieber OM.
    Clin Cancer Res; 2013 Jun 15; 19(12):3285-96. PubMed ID: 23633456
    [Abstract] [Full Text] [Related]

  • 19. Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas.
    Barbareschi M, Buttitta F, Felicioni L, Cotrupi S, Barassi F, Del Grammastro M, Ferro A, Dalla Palma P, Galligioni E, Marchetti A.
    Clin Cancer Res; 2007 Oct 15; 13(20):6064-9. PubMed ID: 17947469
    [Abstract] [Full Text] [Related]

  • 20. Intraductal carcinosarcoma with a heterologous mesenchymal component originating in intraductal papillary-mucinous carcinoma (IPMC) of the pancreas with both carcinoma and osteosarcoma cells arising from IPMC cells.
    Okamura J, Sekine S, Nara S, Ojima H, Shimada K, Kanai Y, Hiraoka N.
    J Clin Pathol; 2010 Mar 15; 63(3):266-9. PubMed ID: 20203229
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.